RTI Surgical Completes Acquisition of Collagen Solutions
ALACHUA, Fla. – RTI Surgical ("RTI" or "the Company"), recognized as a top player in Contract Development and Manufacturing Organization (CDMO), recently announced the completion of its strategic acquisition of Collagen Solutions. This acquisition, finalized following a prior announcement, solidifies RTI's standing in the regenerative medicine field by incorporating a premier supplier of engineered medical-grade collagen and xenograft tissues into its operations.
Expanding Capabilities and Market Reach
The integration of Collagen Solutions into RTI's framework significantly broadens its already extensive portfolio, enhancing access to diverse biomaterials. The recent acquisition follows RTI's earlier purchase of Cook Biotech, providing a well-rounded offering to various therapeutic areas, including cardiac, sports medicine, orthopedics, and plastic and reconstructive surgery.
Specialized Knowledge and Experience
With a combined 50 years of expertise in developing essential products for regenerative medicine, both RTI and Collagen Solutions aim to cater to the needs of millions of patients. This partnership establishes a robust foundation for a more extensive array of solutions tailored to promote healing and accelerate recovery.
About RTI Surgical
RTI Surgical is firmly positioned at the forefront of innovation within the regenerative medicine space. The company prides itself on partnering with Original Equipment Manufacturers (OEMs) to address clinical challenges through tailored solutions that enhance patient outcomes.
Focus Areas and Commitment to Quality
Specializing in critical segments such as plastic and reconstructive surgery, cardiac care, sports medicine, and neuro and spine surgery, RTI utilizes its vast collection of biological materials to develop effective healing solutions. The company's headquarters are in Alachua, Florida, with manufacturing capabilities extending across the United States and Europe. In July 2020, RTI was acquired by Montagu, marking a significant step in its growth trajectory.
Future Outlook for RTI Surgical
The acquisition of Collagen Solutions opens doors to exciting possibilities for RTI Surgical, allowing for innovative product development that meets the evolving needs of the healthcare industry. The increased customer base and enhanced material offerings position RTI well for future growth and success in the dynamic field of regenerative medicine.
Frequently Asked Questions
What prompted RTI Surgical's acquisition of Collagen Solutions?
The acquisition aimed to enhance RTI Surgical's portfolio in regenerative medicine and expand its capabilities in developing medical-grade collagen and xenograft materials.
How does this acquisition benefit RTI's customers?
This purchase allows RTI to offer a more comprehensive range of products, improving solutions for cardiac, sports medicine, orthopedics, and reconstructive surgeries.
What experience does Collagen Solutions bring to RTI Surgical?
Collagen Solutions contributes over 50 years of combined experience in medical-grade collagen materials, elevating RTI's offerings in regenerative medicine.
Where are the headquarters of RTI Surgical located?
RTI Surgical's headquarters is in Alachua, Florida, with additional manufacturing facilities across the U.S. and Europe.
What is RTI Surgical's core mission in the medical field?
RTI Surgical aims to advance patient care by developing innovative solutions that facilitate healing, expedite recovery, and minimize complications in various medical specialties.
